These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8403297

  • 1. Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects.
    Lidón RM, Théroux P, Juneau M, Adelman B, Maraganore J.
    Circulation; 1993 Oct; 88(4 Pt 1):1495-501. PubMed ID: 8403297
    [Abstract] [Full Text] [Related]

  • 2. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.
    Fuchs J, Cannon CP.
    Circulation; 1995 Aug 15; 92(4):727-33. PubMed ID: 7641350
    [Abstract] [Full Text] [Related]

  • 3. Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease.
    Cannon CP, Maraganore JM, Loscalzo J, McAllister A, Eddings K, George D, Selwyn AP, Adelman B, Fox I, Braunwald E.
    Am J Cardiol; 1993 Apr 01; 71(10):778-82. PubMed ID: 8456753
    [Abstract] [Full Text] [Related]

  • 4. Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris.
    Sharma GV, Lapsley D, Vita JA, Sharma S, Coccio E, Adelman B, Loscalzo J.
    Am J Cardiol; 1993 Dec 15; 72(18):1357-60. PubMed ID: 8256726
    [Abstract] [Full Text] [Related]

  • 5. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.
    Eur Heart J; 1996 Aug 15; 17(8):1207-15. PubMed ID: 8869862
    [Abstract] [Full Text] [Related]

  • 6. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK, Sun L, Chesebro JH, Fuster V, Harrington RA, Schwartz D, Gallo P, Matos D, Topol EJ.
    Circulation; 1996 Nov 15; 94(10):2389-95. PubMed ID: 8921778
    [Abstract] [Full Text] [Related]

  • 7. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P, Pérez-Villa F, Waters D, Lespérance J, Shabani F, Bonan R.
    Circulation; 1995 Apr 15; 91(8):2132-9. PubMed ID: 7697841
    [Abstract] [Full Text] [Related]

  • 8. Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans.
    Fox I, Dawson A, Loynds P, Eisner J, Findlen K, Levin E, Hanson D, Mant T, Wagner J, Maraganore J.
    Thromb Haemost; 1993 Feb 01; 69(2):157-63. PubMed ID: 8456428
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK, Torres FW, Garabedian HD, Werner W, Jang IK, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB.
    J Am Coll Cardiol; 1993 Apr 01; 21(5):1039-47. PubMed ID: 8459055
    [Abstract] [Full Text] [Related]

  • 10. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.
    Topol EJ, Bonan R, Jewitt D, Sigwart U, Kakkar VV, Rothman M, de Bono D, Ferguson J, Willerson JT, Strony J.
    Circulation; 1993 May 01; 87(5):1622-9. PubMed ID: 8491018
    [Abstract] [Full Text] [Related]

  • 11. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD, St Pierre A, Leblond L, Deschenes I, DiMaio J, Winocour PD.
    Thromb Haemost; 1998 Feb 01; 79(2):431-8. PubMed ID: 9493603
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model.
    Hamelink JK, Tang DB, Barr CF, Jackson MR, Reid TJ, Gomez ER, Alving BM.
    J Vasc Surg; 1995 Mar 01; 21(3):492-8. PubMed ID: 7877232
    [Abstract] [Full Text] [Related]

  • 13. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
    Topol EJ, Fuster V, Harrington RA, Califf RM, Kleiman NS, Kereiakes DJ, Cohen M, Chapekis A, Gold HK, Tannenbaum MA.
    Circulation; 1994 Apr 01; 89(4):1557-66. PubMed ID: 8149521
    [Abstract] [Full Text] [Related]

  • 14. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI, Plosker GL.
    Drugs; 2002 Apr 01; 62(5):841-70. PubMed ID: 11929334
    [Abstract] [Full Text] [Related]

  • 15. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 01; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects on thrombin generation of single injections of Hirulog in patients with calf vein thrombosis.
    Ginsberg JS, Nurmohamed MT, Gent M, MacKinnon B, Stevens P, Weitz J, Maraganore J, Hirsh J.
    Thromb Haemost; 1994 Oct 01; 72(4):523-5. PubMed ID: 7878625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Unstable angina pectoris: coagulation disorder and its therapy].
    Meyer BJ.
    Praxis (Bern 1994); 1995 Feb 21; 84(8):232-8. PubMed ID: 7886362
    [Abstract] [Full Text] [Related]

  • 20. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
    Mombelli G, Marchetti O, Haeberli A, Straub PW.
    Am Heart J; 1998 Dec 21; 136(6):1106-13. PubMed ID: 9842027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.